Clinical Trial Update: A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating selexipag for chronic thromboembolic pulmonary hypertension in patients inoperable or with persistent/recurrent disease after surgery w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Uptravi (selexipag)

Snippet

Sponsor: Actelion | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2023-08-09